Jorge Plutzky

26.6k total citations · 12 hit papers
186 papers, 18.1k citations indexed

About

Jorge Plutzky is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Jorge Plutzky has authored 186 papers receiving a total of 18.1k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Molecular Biology, 66 papers in Endocrinology, Diabetes and Metabolism and 50 papers in Surgery. Recurrent topics in Jorge Plutzky's work include Peroxisome Proliferator-Activated Receptors (45 papers), Lipoproteins and Cardiovascular Health (43 papers) and Diabetes Treatment and Management (36 papers). Jorge Plutzky is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (45 papers), Lipoproteins and Cardiovascular Health (43 papers) and Diabetes Treatment and Management (36 papers). Jorge Plutzky collaborates with scholars based in United States, United Kingdom and Denmark. Jorge Plutzky's co-authors include Peter Libby, Nikolaus Marx, James K. Liao, Ulrich Laufs, Gabriela Orasanu, Jonathan D. Brown, Galina K. Sukhova, Ouliana Ziouzenkova, Benjamin G. Neel and Alan Chait and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Jorge Plutzky

181 papers receiving 17.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors

1998 1.5k citations Jorge Plutzky et al. Circulation profile →
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

2023 1.3k citations A. Michael Lincoff, Kirstine Brown‐Frandsen et al. profile →
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors

2006 813 citations Joel P. Berger, Jorge Plutzky et al. profile →
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus

2006 788 citations Jorge Plutzky et al. profile →
Peroxisome Proliferator-Activated Receptor Gamma Activators Inhibit Gene Expression and Migration in Human Vascular Smooth Muscle Cells

1998 514 citations Nikolaus Marx, Peter Libby et al. profile →
PPARα Activators Inhibit Cytokine-Induced Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells

1999 504 citations Nikolaus Marx, Peter Libby et al. Circulation profile →
NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis

2014 453 citations Jorge Plutzky et al. profile →
Discontinuation of Statins in Routine Care Settings

2013 422 citations Huabing Zhang, Jorge Plutzky et al. profile →
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial

2024 123 citations Donna H. Ryan, Ildiko Lingvay et al. profile →
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials

2024 123 citations Scott S. Emerson, Steven E. Kahn et al. profile →
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

2024 102 citations Helen M. Colhoun, Ildiko Lingvay et al. profile →
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

2024 100 citations Subodh Verma, Benjamin M. Scirica et al. profile →

Peers

Countries citing papers authored by Jorge Plutzky

Since Specialization

Citations

This map shows the geographic impact of Jorge Plutzky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Plutzky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Plutzky more than expected).

Fields of papers citing papers by Jorge Plutzky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Plutzky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Plutzky. The network helps show where Jorge Plutzky may publish in the future.

Co-authorship network of co-authors of Jorge Plutzky

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Plutzky. A scholar is included among the top collaborators of Jorge Plutzky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Plutzky. Jorge Plutzky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Type 2 diabetes disease and management patterns across a large, diverse healthcare system: Issues and opportunities for guideline-directed therapies 2025 ·American Heart Journal ·Alexander Blood, Lee‐Shing Chang, (unknown), (unknown), (unknown), (unknown), (unknown), Joshua Noone, (unknown), Samuel Aronson, Thomas A. Gaziano, Lina Matta, Jorge Plutzky, Christopher P. Cannon, Deborah J. Wexler, Benjamin M. Scirica	2
2	The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes 2025 ·Advances in Therapy ·(unknown), (unknown), Ruben Vale, Scott S. Emerson, (unknown), Jorge Plutzky, Geraint Roberts, (unknown), A. Michael Lincoff	2
3	Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) 2024 ·Journal of the American College of Cardiology ·Subodh Verma, Helen M. Colhoun, Dror Dicker, G. Kees Hovingh, Steven E. Kahn, Alexandra Kautzky‐Willer, Ildiko Lingvay, Jorge Plutzky, (unknown), Naveen Rathor, Søren T. Hoff, A. Michael Lincoff	11
4	Semaglutide and cardiovascular outcomes in patients with overweight or obesity who do not have diabetes 2024 ·Obesity Research & Clinical Practice ·(unknown), (unknown), Kirstine Brown‐Frandsen, Helen M. Colhoun, John Deanfield, Scott S. Emerson, Sille Esbjerg, Søren Hardt‐Lindberg, G. Kees Hovingh, Steven E. Kahn, Robert F. Kushner, Ildiko Lingvay, Tuğçe Kalaycı Oral, Marie Mide Michelsen, Jorge Plutzky, Christoffer W. Tornøe, Donna H. Ryan	1
5	Cardiovascular Risk Estimation Is Suboptimal in People With HIV 2024 ·Journal of the American Heart Association ·Virginia A. Triant, Asya Lyass, Leo B. Hurley, Leila H. Borowsky, (unknown), Wei He, David Cheng, Janet Lo, Daniel B. Klein, James B. Meigs, Steven Grinspoon, Jorge Plutzky, Michael J. Silverberg, Michael P. LaValley, Joseph M. Massaro, Ralph B. D’Agostino	11
6	Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE Trial 2024 ·Circulation ·Alexander Blood, Lee‐Shing Chang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Samuel Aronson, (unknown), Emma Collins, (unknown), (unknown), Joshua Noone, (unknown), Jorge Plutzky, Thomas A. Gaziano, Christopher P. Cannon, Deborah J. Wexler, Benjamin M. Scirica	10
7	Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) Registry 2024 ·Journal of the American Heart Association ·Arthur Shiyovich, Adam N. Berman, Stephanie A. Besser, David Biery, Gurleen Kaur, Sanjay Divakaran, Avinainder Singh, Daniel Huck, Brittany Weber, Jorge Plutzky, Marcelo F. Di Carli, Khurram Nasir, Christopher P. Cannon, James L. Januzzi, Deepak L. Bhatt, Ron Blankstein	9
8	Semaglutide, inflammatory markers and cardiovascular outcomes in patients with overweight or obesity in the select trial 2024 ·Atherosclerosis ·Jorge Plutzky, Paweł Bogdański, Selçuk Dağdelen, John Deanfield, Scott S. Emerson, G. Kees Hovingh, Steven E. Kahn, (unknown), Gustavs Latkovskis, Michael Lehrke, Søren Hardt‐Lindberg, Ildiko Lingvay, Stephen C. Nicholls, Tuğçe Kalaycı Oral, (unknown), (unknown), Paul M. Ridker, Donna H. Ryan, A. Michael Lincoff	1
9	FAM222A, Part of the BET-Regulated Basal Endothelial Transcriptome, Is a Novel Determinant of Endothelial Biology and Angiogenesis—Brief Report 2023 ·Arteriosclerosis Thrombosis and Vascular Biology ·Aspasia Tzani, Stefan Haemmig, Henry S. Cheng, Daniel Pérez‐Cremades, (unknown), (unknown), Sasha A. Singh, Masanori Aikawa, Paul B. Yu, (unknown), Ye Sun, Mark W. Feinberg, Jorge Plutzky	2
10	A miRNA/CXCR4 signaling axis impairs monopoiesis and angiogenesis in diabetic critical limb ischemia 2023 ·JCI Insight ·Henry S. Cheng, Rulin Zhuang, Daniel Pérez‐Cremades, Jingshu Chen, (unknown), Winona Wu, Grasiele Sausen, Aspasia Tzani, Jorge Plutzky, Jorge Henao‐Mejia, Philip P. Goodney, Mark A. Creager, Marc S. Sabatine, Marc P. Bonaca, Mark W. Feinberg	9
11	Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation 2020 ·Arthritis & Rheumatology ·Brittany Weber, Zhe He, Nicole Yang, Martin P. Playford, Dana Weisenfeld, Christine Iannaccone, Jonathan S. Coblyn, Michael E. Weinblatt, Nancy A. Shadick, Marcelo F. Di Carli, Nehal N. Mehta, Jorge Plutzky, Katherine P. Liao	17
12	Intact vitamin A transport is critical for cold-mediated adipose tissue browning and thermogenesis 2020 ·Molecular Metabolism ·Anna Fenzl, Oana C. Kulterer, (unknown), Goran Mitulović, Rodrig Marculescu, Martin Bilban, Sabina Baumgartner‐Parzer, Alexandra Kautzky‐Willer, Lukas Kenner, Jorge Plutzky, Loredana Quadro, Florian W. Kiefer	18
13	Predictors of a successful statin reattempt after an adverse reaction 2018 ·Journal of clinical lipidology ·Huabing Zhang, Jorge Plutzky, Wendong Ge, Maria Shubina, Alexander Turchin	5
14	A REMOTE LIPID MANAGEMENT PROGRAM IMPROVES APPROPRIATE STATIN USE AND CHOLESTEROL LEVELS ACROSS A WIDE POPULATION OF HIGH CARDIOVASCULAR RISK PATIENTS 2018 ·Journal of the American College of Cardiology ·Mark D. Benson, (unknown), Lina Matta, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Thomas A. Gaziano, Calum A. MacRae, (unknown), Jorge Plutzky	4
15	Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice 2011 ·Diabetologia ·Florian W. Kiefer, Susanne Neschen, (unknown), (unknown), Angelika Neuhofer, Melanie Kahle, Martin Hrabě de Angelis, Michaela Schlederer, Markus Mair, Lukas Kenner, Jorge Plutzky, Maximilian Zeyda, Thomas M. Stulnig	83
16	Retinoid metabolism and its effects on the vasculature 2011 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Eun‐Jung Rhee, Shriram Nallamshetty, Jorge Plutzky	46
17	Lipolytic PPAR activation: new insights into the intersection of triglycerides and inflammation? 2004 ·Current Opinion in Clinical Nutrition & Metabolic Care ·Ouliana Ziouzenkova, Jorge Plutzky	20
18	Dual Roles for Lipolysis and Oxidation in Peroxisome Proliferation-Activator Receptor Responses to Electronegative Low Density Lipoprotein 2003 ·Journal of Biological Chemistry ·Ouliana Ziouzenkova, Liana Asatryan, (unknown), Gabriela Orasanu, Stéphane Perrey, (unknown), Tom Hassell, Taro E. Akiyama, Joel P. Berger, Alex Sevanian, Jorge Plutzky	52
19	Peroxisome Proliferator-Activated Receptors (PPARs) and Their Role in the Vessel Wall: Possible Mediators of Cardiovascular Risk? 2001 ·European Journal of Cardiovascular Prevention & Rehabilitation ·Nikolaus Marx, Peter Libby, Jorge Plutzky	42
20	Peroxisome Proliferator-Activated Receptor-γ Activators Inhibit IFN-γ-Induced Expression of the T Cell-Active CXC Chemokines IP-10, Mig, and I-TAC in Human Endothelial Cells 2000 ·The Journal of Immunology ·Nikolaus Marx, François Mach, Alain Sauty, (unknown), (unknown), Richard M. Ransohoff, Peter Libby, Jorge Plutzky, Andrew D. Luster	261

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact